CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | SING GEORGE L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,958 | 1,958 | ||
| 2024-12-31 | SING GEORGE L Director | Option exercise | +3,338 | $413.33 | $1.4M | 29,610 |
| 2024-12-31 | SING GEORGE L Director | Shares withheld for taxes | −1,948 | $708.19 | $1.4M | 27,662 |
| 2024-12-31 | SING GEORGE L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,338 | 0 | ||
| 2024-12-20 | POON CHRISTINE A Director | Other acquisition | +14 | 2,186 | ||
| 2024-12-16 | Van Plew Daniel P EVP & General Mgr, Industrial | Shares withheld for taxes | −969 | $730.81 | $708K | 34,792 |
| 2024-12-16 | STAHL NEIL EVP Research and Development | Shares withheld for taxes | −304 | $730.81 | $222K | 48,829 |
| 2024-12-16 | Pitofsky Jason VP Controller | Shares withheld for taxes | −298 | $730.81 | $218K | 4,664 |
| 2024-12-16 | MURPHY ANDREW J EVP Research | Shares withheld for taxes | −1,054 | $730.81 | $770K | 49,074 |
| 2024-12-16 | McCourt Marion EVP Commercial | Shares withheld for taxes | −759 | $730.81 | $555K | 14,230 |
| 2024-12-16 | LAROSA JOSEPH J EVP General Counsel and Secret | Shares withheld for taxes | −702 | $730.81 | $513K | 30,075 |
| 2024-12-16 | Fenimore Christopher R. SVP Finance & CFO | Shares withheld for taxes | −491 | $730.81 | $359K | 16,265 |
| 2024-12-09 | STAHL NEIL EVP Research and Development | Shares withheld for taxes | −466 | $787.00 | $367K | 49,133 |
| 2024-12-09 | MURPHY ANDREW J EVP Research | Shares withheld for taxes | −492 | $787.00 | $387K | 50,128 |
| 2024-12-09 | McCourt Marion EVP Commercial | Shares withheld for taxes | −274 | $787.00 | $216K | 14,989 |
| 2024-12-09 | LAROSA JOSEPH J EVP General Counsel and Secret | Shares withheld for taxes | −492 | $787.00 | $387K | 30,777 |
| 2024-12-09 | Pitofsky Jason VP Controller | Shares withheld for taxes | −149 | $787.00 | $117K | 4,962 |
| 2024-12-09 | Fenimore Christopher R. SVP Finance & CFO | Shares withheld for taxes | −1,140 | $787.00 | $897K | 16,756 |
| 2024-12-09 | Van Plew Daniel P EVP & General Mgr, Industrial | Shares withheld for taxes | −492 | $787.00 | $387K | 35,761 |
| 2024-12-06 | MURPHY ANDREW J EVP Research | Grant or award | +3,499 | 50,620 |
Page 15 of 49 · 971 trades